Starpharma Holdings Limited (AU:SPL) has released an update.
Starpharma Holdings Limited has reported a change in the interests of Director Robert B. Thomas, who has acquired an additional 250,000 ordinary shares through an on-market purchase. This transaction has increased Thomas’s indirect holding to 1,025,000 ordinary shares in the company, valued at $0.145 per share. The change, which occurred on April 10, 2024, was disclosed in compliance with ASX listing rules.
For further insights into AU:SPL stock, check out TipRanks’ Stock Analysis page.
